Changes in the indications for and outcomes of gastrostomy tube placement: an analysis of serial, prospective multi-site audits in Northern England - Takeaways - MDSpire

Trends in Indications and Outcomes of Gastrostomy Tube Insertion: Insights from Multi-Site Prospective Audits in Northern England

  • By

  • Alice Rose Weidner

  • Christopher G Mountford

  • David Oliver

  • Chris Wells

  • Jo Hulley

  • Emma Johns

  • Nick Thompson

  • on behalf of the Northern Nutrition Network

  • July 16, 2026

Share

  • 1

    A total of 889 gastrostomy procedures were performed across Northern England from 2004 to 2022, with a decreasing mean patient age from 71 to 63 years.

  • 2

    The most common indication for gastrostomy placement shifted from stroke to dysphagia due to ear-nose-throat/upper gastrointestinal malignancies over the study period.

  • 3

    Prophylactic antibiotic use increased from 83% to 93% between 2004 and 2022, indicating a trend towards improved pre-procedural care.

  • 4

    7-day mortality rates decreased from 2% in 2004 to 1% in 2022, while 30-day mortality rates fell from 9% to 2.5% during the same period.

  • 5

    Dementia is no longer a listed indication for gastrostomy placement, aligning with international guidelines on patient selection.

Original Source(s)

Changes in the indications for and outcomes of gastrostomy tube placement: an analysis of serial, prospective multi-site audits in Northern England

  • by Alice Rose Weidner, Christopher G Mountford, David Oliver, Chris Wells, Jo Hulley, Emma Johns, Nick Thompson, on behalf of the Northern Nutrition Network

  • July 16, 2026

Related Content

Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography-Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos)

Impact of multi-channel follow-up as continuous nursing on cancer pain control, adverse reactions, and quality of life in patients with digestive tract tumors: a controlled study of 136 cases

Targeting stroma-mediated T-cell exclusion and functional exhaustion in pancreatic ductal adenocarcinoma through CXCR4 and PD-1 blockade